US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 7.0300
  • -0.4800-6.39%
Close Jan 8 16:00 ET
73.56MMarket Cap0.07P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.2M
-14.69%-30.68M
29.80%-2.77M
-219.39%-6.84M
11.58%-11.03M
37.44%-10.05M
62.27%-26.75M
76.96%-3.94M
Net income from continuing operations
540.65%23.04M
1,301.79%98.46M
-1,118.38%-121.29M
24.28%-31.54M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
50.63%-41.66M
48.89%-9.81M
Operating gains losses
-34,825.00%-34.93M
-69,425.00%-27.73M
-33.33%120K
-87.65%720K
--600K
---100K
--40K
--180K
--5.83M
----
Depreciation and amortization
-17.07%34K
-19.51%33K
3.03%34K
-4.82%158K
22.86%43K
20.59%41K
36.67%41K
-50.75%33K
-89.98%166K
-88.14%35K
Deferred tax
-275.00%-14K
0.00%7K
-12.50%7K
-50.00%14K
-212.50%-9K
60.00%8K
16.67%7K
-11.11%8K
27.27%28K
144.44%8K
Other non cash items
--0
-24,799.43%-86.2M
32,917.43%115.56M
31.61%1.83M
--0
218.93%1.13M
3.87%349K
0.00%350K
74.94%1.39M
0.00%349K
Change In working capital
58.59%-1.51M
68.15%-1.33M
17.07%-1.26M
-15,300.00%-9.24M
144.04%85K
-358.09%-3.64M
-173.34%-4.16M
-719.11%-1.52M
-102.11%-60K
54.16%-193K
-Change in receivables
35.41%-965K
-99.75%2K
-90.49%101K
-38.09%1.78M
331.74%1.4M
-378.73%-1.49M
52.82%813K
-56.06%1.06M
795.65%2.88M
31.79%-605K
-Change in inventory
--0
--0
--0
11.11%20K
--0
1,700.00%18K
-50.00%1K
-92.31%1K
151.43%18K
109.09%2K
-Change in prepaid assets
-518.46%-816K
-392.28%-1.44M
54.30%-154K
-58.69%447K
156.40%97K
-74.58%195K
-38.27%492K
-8.71%-337K
277.00%1.08M
82.18%-172K
-Change in payables and accrued expense
112.42%301K
102.47%136K
47.65%-1.18M
-178.81%-11.48M
-237.49%-1.3M
-648.15%-2.42M
-93.46%-5.5M
-18.90%-2.26M
-201.80%-4.12M
111.38%947K
-Change in other current liabilities
463.64%80K
247.06%25K
-1,330.77%-186K
-744.44%-76K
-118.18%-24K
-83.33%-22K
-54.55%-17K
-152.00%-13K
80.00%-9K
-320.00%-11K
-Change in other working capital
----
-206.25%-51K
618.18%158K
-20.45%70K
75.14%-88K
--88K
--48K
--22K
--88K
---354K
Cash from discontinued investing activities
Operating cash flow
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.2M
-14.69%-30.68M
29.80%-2.77M
-219.39%-6.84M
11.58%-11.03M
37.44%-10.05M
62.27%-26.75M
76.96%-3.94M
Investing cash flow
Cash flow from continuing investing activities
0
0
367.67%356K
-40.00%-133K
0
0
0
-133K
15.93%-95K
0
Net PPE purchase and sale
--0
--0
--0
126.32%25K
--0
--0
--0
--25K
15.93%-95K
--0
Net business purchase and sale
--0
--0
--356K
----
----
--0
--0
--0
----
----
Net other investing changes
----
----
----
---158K
--0
--0
--0
---158K
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
367.67%356K
-40.00%-133K
--0
--0
--0
---133K
15.93%-95K
--0
Financing cash flow
Cash flow from continuing financing activities
0
-178.93%-472K
690.02%108.61M
270.37%25.04M
-98.78%1K
10.7M
104.05%598K
13.75M
-113.77%-14.7M
7.89%82K
Net issuance payments of debt
--0
----
----
---21.24M
--0
---15.24M
----
----
--0
--14.81M
Net common stock issuance
--0
--0
741.03%115.63M
412.88%46.22M
100.01%1K
--25.94M
--6.53M
--13.75M
-120.54%-14.77M
-17,914.63%-14.77M
Proceeds from stock option exercised by employees
--0
----
----
-8.22%67K
--0
--0
----
----
-96.22%73K
-69.62%48K
Net other financing activities
--0
---472K
---7.01M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-178.93%-472K
690.02%108.61M
270.37%25.04M
-98.78%1K
--10.7M
104.05%598K
--13.75M
-113.77%-14.7M
7.89%82K
Net cash flow
Beginning cash position
1,349.82%93.56M
553.47%110.31M
-43.34%7.55M
-75.72%13.32M
-39.97%10.31M
-43.84%6.45M
-56.49%16.88M
-75.72%13.32M
187.15%54.86M
-76.11%17.18M
Current changes in cash
-398.70%-11.53M
-60.67%-16.76M
2,784.25%102.77M
86.11%-5.77M
28.33%-2.77M
-32.14%3.86M
61.81%-10.43M
122.18%3.56M
-216.19%-41.55M
77.35%-3.86M
End cash Position
695.48%82.03M
1,349.82%93.56M
553.47%110.31M
-43.33%7.55M
-43.33%7.55M
-39.97%10.31M
-43.84%6.45M
-56.49%16.88M
-75.72%13.32M
-75.72%13.32M
Free cash flow
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.2M
-14.28%-30.68M
29.80%-2.77M
-220.20%-6.84M
11.98%-11.03M
37.44%-10.05M
62.19%-26.85M
76.97%-3.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -68.62%-11.53M -47.68%-16.28M 38.30%-6.2M -14.69%-30.68M 29.80%-2.77M -219.39%-6.84M 11.58%-11.03M 37.44%-10.05M 62.27%-26.75M 76.96%-3.94M
Net income from continuing operations 540.65%23.04M 1,301.79%98.46M -1,118.38%-121.29M 24.28%-31.54M 16.75%-8.17M -263.78%-5.23M 36.91%-8.19M 54.85%-9.96M 50.63%-41.66M 48.89%-9.81M
Operating gains losses -34,825.00%-34.93M -69,425.00%-27.73M -33.33%120K -87.65%720K --600K ---100K --40K --180K --5.83M ----
Depreciation and amortization -17.07%34K -19.51%33K 3.03%34K -4.82%158K 22.86%43K 20.59%41K 36.67%41K -50.75%33K -89.98%166K -88.14%35K
Deferred tax -275.00%-14K 0.00%7K -12.50%7K -50.00%14K -212.50%-9K 60.00%8K 16.67%7K -11.11%8K 27.27%28K 144.44%8K
Other non cash items --0 -24,799.43%-86.2M 32,917.43%115.56M 31.61%1.83M --0 218.93%1.13M 3.87%349K 0.00%350K 74.94%1.39M 0.00%349K
Change In working capital 58.59%-1.51M 68.15%-1.33M 17.07%-1.26M -15,300.00%-9.24M 144.04%85K -358.09%-3.64M -173.34%-4.16M -719.11%-1.52M -102.11%-60K 54.16%-193K
-Change in receivables 35.41%-965K -99.75%2K -90.49%101K -38.09%1.78M 331.74%1.4M -378.73%-1.49M 52.82%813K -56.06%1.06M 795.65%2.88M 31.79%-605K
-Change in inventory --0 --0 --0 11.11%20K --0 1,700.00%18K -50.00%1K -92.31%1K 151.43%18K 109.09%2K
-Change in prepaid assets -518.46%-816K -392.28%-1.44M 54.30%-154K -58.69%447K 156.40%97K -74.58%195K -38.27%492K -8.71%-337K 277.00%1.08M 82.18%-172K
-Change in payables and accrued expense 112.42%301K 102.47%136K 47.65%-1.18M -178.81%-11.48M -237.49%-1.3M -648.15%-2.42M -93.46%-5.5M -18.90%-2.26M -201.80%-4.12M 111.38%947K
-Change in other current liabilities 463.64%80K 247.06%25K -1,330.77%-186K -744.44%-76K -118.18%-24K -83.33%-22K -54.55%-17K -152.00%-13K 80.00%-9K -320.00%-11K
-Change in other working capital ---- -206.25%-51K 618.18%158K -20.45%70K 75.14%-88K --88K --48K --22K --88K ---354K
Cash from discontinued investing activities
Operating cash flow -68.62%-11.53M -47.68%-16.28M 38.30%-6.2M -14.69%-30.68M 29.80%-2.77M -219.39%-6.84M 11.58%-11.03M 37.44%-10.05M 62.27%-26.75M 76.96%-3.94M
Investing cash flow
Cash flow from continuing investing activities 0 0 367.67%356K -40.00%-133K 0 0 0 -133K 15.93%-95K 0
Net PPE purchase and sale --0 --0 --0 126.32%25K --0 --0 --0 --25K 15.93%-95K --0
Net business purchase and sale --0 --0 --356K ---- ---- --0 --0 --0 ---- ----
Net other investing changes ---- ---- ---- ---158K --0 --0 --0 ---158K ---- ----
Cash from discontinued investing activities
Investing cash flow --0 --0 367.67%356K -40.00%-133K --0 --0 --0 ---133K 15.93%-95K --0
Financing cash flow
Cash flow from continuing financing activities 0 -178.93%-472K 690.02%108.61M 270.37%25.04M -98.78%1K 10.7M 104.05%598K 13.75M -113.77%-14.7M 7.89%82K
Net issuance payments of debt --0 ---- ---- ---21.24M --0 ---15.24M ---- ---- --0 --14.81M
Net common stock issuance --0 --0 741.03%115.63M 412.88%46.22M 100.01%1K --25.94M --6.53M --13.75M -120.54%-14.77M -17,914.63%-14.77M
Proceeds from stock option exercised by employees --0 ---- ---- -8.22%67K --0 --0 ---- ---- -96.22%73K -69.62%48K
Net other financing activities --0 ---472K ---7.01M ---- ---- ---- ---- ---- ---- ----
Cash from discontinued financing activities
Financing cash flow --0 -178.93%-472K 690.02%108.61M 270.37%25.04M -98.78%1K --10.7M 104.05%598K --13.75M -113.77%-14.7M 7.89%82K
Net cash flow
Beginning cash position 1,349.82%93.56M 553.47%110.31M -43.34%7.55M -75.72%13.32M -39.97%10.31M -43.84%6.45M -56.49%16.88M -75.72%13.32M 187.15%54.86M -76.11%17.18M
Current changes in cash -398.70%-11.53M -60.67%-16.76M 2,784.25%102.77M 86.11%-5.77M 28.33%-2.77M -32.14%3.86M 61.81%-10.43M 122.18%3.56M -216.19%-41.55M 77.35%-3.86M
End cash Position 695.48%82.03M 1,349.82%93.56M 553.47%110.31M -43.33%7.55M -43.33%7.55M -39.97%10.31M -43.84%6.45M -56.49%16.88M -75.72%13.32M -75.72%13.32M
Free cash flow -68.62%-11.53M -47.68%-16.28M 38.30%-6.2M -14.28%-30.68M 29.80%-2.77M -220.20%-6.84M 11.98%-11.03M 37.44%-10.05M 62.19%-26.85M 76.97%-3.94M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Symbol Mini Chart % Chg
Moody's
MCO
+1.75%
Coca-Cola
KO
+1.43%
VeriSign
VRSN
+1.17%
MasterCard
MA
+0.98%
DaVita
DVA
+0.83%

Unlock the Full List